Title : Effect of saquinavir/ritonavir on P-glycoprotein activity in healthy volunteers using digoxin as a probe.

Pub. Date : 2010 Mar

PMID : 20197013






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Effect of saquinavir/ritonavir on P-glycoprotein activity in healthy volunteers using digoxin as a probe. Saquinavir ATP binding cassette subfamily B member 1 Homo sapiens
2 BACKGROUND: Saquinavir and ritonavir, both human immunodeficiency virus-1 protease inhibitors, also inhibit the adenosine triphosphate-dependent efflux pump P-glycoprotein (P-gp), which is located at a variety of anatomic sites, including the human intestine. Saquinavir ATP binding cassette subfamily B member 1 Homo sapiens
3 BACKGROUND: Saquinavir and ritonavir, both human immunodeficiency virus-1 protease inhibitors, also inhibit the adenosine triphosphate-dependent efflux pump P-glycoprotein (P-gp), which is located at a variety of anatomic sites, including the human intestine. Saquinavir ATP binding cassette subfamily B member 1 Homo sapiens
4 CONCLUSIONS: Pretreatment with saquinavir/ritonavir 1,000/100 mg twice daily increased digoxin exposure most likely via P-gp-inhibition. Saquinavir ATP binding cassette subfamily B member 1 Homo sapiens